Related Experiment Video
Updated: Jul 3, 2025
11:13
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
1.5K
PPIP5K2 Facilitates Proliferation and Metastasis of Non-Small Lung Cancer (NSCLC) through AKT Signaling Pathway
Qi Yang1, Chenhui Cao2, Binghuo Wu3
1Biotherapy Center, Harbin Medical University Cancer Hospital, Harbin 150001, China.
Cancers
|February 10, 2024
Summary
The protein PPIP5K2 promotes non-small cell lung cancer (NSCLC) growth and metastasis by activating the AKT/mTOR pathway. Targeting PPIP5K2 may offer a new therapeutic strategy for NSCLC patients.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Previous research established PPIP5K2's role in colorectal cancer survival via DNA repair.
- The function of PPIP5K2 in non-small cell lung cancer (NSCLC) tumorigenesis remained uninvestigated.
- NSCLC is a leading cause of cancer-related mortality worldwide.
Purpose of the Study:
- To investigate the role of PPIP5K2 in NSCLC proliferation and metastasis.
- To elucidate the underlying molecular mechanism of PPIP5K2 in NSCLC.
- To explore PPIP5K2 as a potential therapeutic target for NSCLC.
Main Methods:
- Loss- and gain-of-function assays were performed in vitro and in vivo.
- Epithelial-mesenchymal transition (EMT) was assessed.
- The AKT/mTOR signaling pathway was analyzed using agonists and antagonists.
Main Results:
- PPIP5K2 significantly impacts NSCLC cell proliferation.
- PPIP5K2 regulates NSCLC cell metastasis through an EMT-dependent mechanism.
- PPIP5K2 modulates AKT/mTOR pathway phosphorylation, influencing NSCLC progression.
Conclusions:
- PPIP5K2 acts as an oncogene in NSCLC.
- PPIP5K2 promotes NSCLC tumorigenesis by activating the AKT/mTOR signaling axis.
- Targeting PPIP5K2 presents a potential therapeutic avenue for NSCLC treatment.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
437
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.9K
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:20The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
01:19Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:07MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K